WHO ICTRP trial
Effects of Lipoxin on Ang Expression in Esophageal Vascular Endothelial Cells…
ChiCTR-OOC-17011222 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-OOC-17011222 |
|---|---|
| Public title | Effects of Lipoxin on Ang Expression in Esophageal Vascular Endothelial Cells and Its Mechanism |
| Scientific title | The relationship between the expression of lipoxygen and Ang in sepsis patients |
| Primary sponsor | Taizhou Hospital of Zhejiang Province |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Other |
| Countries | China |
| Conditions | sepsis |
| Interventions | Case series:no |
| Registration date | Apr 23, 2017 |
| Target size | Case series:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: